MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202617074131 A) filed by Inventage Lab Inc. on June 15, 2026, for Microparticles Comprising Tirzepatide Or Pharmaceutically Acceptable Salt Thereof, And Manufacturing Method Therefor.
Inventors include Kim, Ju Hee; and Lee, Sang No.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: The present invention relates to microparticles comprising tirzepatide or a pharmaceutically acceptable salt thereof and a manufacturing method therefor, wherein the content of tirzepatide or a pharmaceutically acceptable salt thereof is increased in the microparticles, thereby increasing the loading amount of a drug in the microparticles and exhibiting an effect of continuously releasing tirzepatide or a pharmaceutically acceptable salt thereof from the microparticles without initial over- release and lag time, thus preventing an excessive decrease in bioavailability. In addition, when the microparticles are used as a subcutaneous injection, the amount of microparticles included for one injection can be reduced, thereby reducing pain at the site of administration and causing no inflammatory response.
Disclaimer: Curated by HT Syndication.
